Pharmafile Logo
Pharmafocus logo
Advanced Search

Trajenta may reduce stroke damage

December 4, 2012
Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …

News

Excipient certification project moves forward

December 4, 2012
Manufacturing and Production DEG, EXCiPACT, GDP, GMP

The EXCiPACT certification scheme for pharmaceutical excipients has taken a step closer to fruition with agreements now in place with …

News

R&D costs rise ten-fold

December 4, 2012
Research and Development, Sales and Marketing OHE, R&D, research and development

Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …

News
Chris Ham image

NHS ‘entering treacherous waters’

December 3, 2012
Sales and Marketing Ham, NHS, coalition, king's fund, reforms

A leading think tank has marked the coalition government’s health policy with what amounts to a C+ in its mid-term …

News

J&J’s Alex Gorsky to be chairman and chief executive

December 3, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson has has elected its chief executive Alex Gorsky to be its chairman of the Board of directors.  …

Appointment

Pharmacos ink green manufacturing pact with EU academics

December 3, 2012
Manufacturing and Production Bayer, EU, Pharmacos, Sanofi

A group of top pharma multinationals have set up a public-private partnership dedicated to the development of manufacturing sustainable pharmaceuticals …

News
janssen image

Janssen eases HIV patent burden

December 3, 2012
Sales and Marketing AIDS, Janssen, Prezista, darunavir

In a move which should appeal to public health campaigners, Janssen has declared that it will not enforce patents for …

News
NHS image

Help CCGs help you, pharma told

November 30, 2012
Medical Communications, Sales and Marketing CCGs, JSNA, NHS, pharma

Pharma companies have a big opportunity to take advantage of the changes in the structure of the NHS, according to …

News
Ranbaxy image

Ranbaxy suspends atorvastatin manufacturing after recall

November 30, 2012
Manufacturing and Production FDA, Ranbaxy, atorvastatin, recall

Ranbaxy Laboratories has called a halt to manufacturing its generic atorvastatin product until it can get to the bottom of …

News
mr_subhanu_saxena__1276617e

New chief executive for Cipla

November 30, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena

Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …

Appointment
NICE image

NICE: ‘lot of work’ to do on VBP

November 30, 2012
Medical Communications, Sales and Marketing Boysen, NHS, NICE, QALY, VBP

NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …

News
Novartis image

Novartis R&D warning

November 29, 2012
Research and Development, Sales and Marketing NHS, Novartis. R&D, trials

Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …

News
Eylea image

Eylea approval for wet AMD

November 29, 2012
Sales and Marketing Bayer, Eylea, Lucentis, Novartis, avastin, wet AMD

Bayer HealthCare’s Eylea has been appoved in Europe for the treatment of neovascular age-related macular degeneration (wet AMD). The eye …

News
screen_shot_2012-11-28_at_15

Genzyme appoints new GM for UK and Ireland

November 29, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brendan Martin, Genzyme

Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …

Appointment

Survey: pharma losing $564 billion each year

November 28, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cap Gemini, Health Prize, pharma

Pharma companies are losing $564 billion each year – more than half the industry’s $956 billion revenue worldwide last year …

News
Humira image

Another indication for Humira

November 28, 2012
Sales and Marketing Abbott, Crohn's, EU, Humira

Abbott’s Humira has received its ninth indication in Europe with approval to treat youngsters suffering from the inflammatory bowel disease …

News
screen_shot_2012-11-27_at_13

RSA welcomes new starter

November 28, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huberts, rsa

Life Sciences Executive Search and Interim Management specialists RSA, has announced that Michael Huberts has joined the UK business as …

Appointment

TranslateMedia listed in the Deloitte UK Fast 50 for the third year running

November 27, 2012
Medical Communications

International translation and transcreation agency, TranslateMedia has been listed in the Deloitte UK Fast 50 for the third consecutive year, …

News
Press release
EMA image

EMA’s five points on data release

November 27, 2012
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency

The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …

News
ABPI image

‘Adopt NICE decisions’ committee told

November 27, 2012
Sales and Marketing ABPI, Dorrell, NHS, NICE, Whitehead

ABPI chief executive Stephen Whitehead has again urged the NHS to adopt and use the drugs which NICE approves, and …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026